A machine learning based-study reported that the 5-gene signature including ANKRD22, ARNTL2, DSG3, KRT7, PRSS3 performed well on both our chosen training dataset and validation dataset and provided a new way to predict the prognosis of pancreatic cancer patients 40. This evidence concerns the gene ANKRD22 and pancreatic neoplasm.